Facebook PixelWet AMD: treating the cause or the effect?
Brainstorming
Brainstorming
Brainstorming session

Wet AMD: treating the cause or the effect?

Wet AMD: treating the cause or the effect?

Image credit: http://advaitatoons.blogspot.com/2005/11/cause-and-effect-duality-illustrated.html

By Shubhankar Kulkarni on Jul 30, 2020

Creative contributions

Antiangiogenic & Alpha-lipoic Therapies

[1] 1. Velez-Montoya R., Oliver S. C. N., Olson J. L., Fine S. L., Mandava N., Quiroz-Mercado H. Current knowledge and trends in age-related macular degeneration: today’s and future treatments. Retina. 2013;33(8):1487–1502

[2] Salvi S. M., Akhtar S., Currie Z. Ageing changes in the eye. Postgraduate Medical Journal. 2006;82(971):581–587

[3] Ashraf M., Souka A. A. R. Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option. Eye. 2017;31(11):1523–1536

[4] Hahn P., Milam A. H., Dunaief J. L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch’s membrane. Archives of Ophthalmology. 2003;121(8):1099–1105

[5] Shaw P. X., Hörkkö S., Chang M. K., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. The Journal of Clinical Investigation. 2000;105(12):1731–1740

[6] Hanus J., Zhao F., Wang S. Current therapeutic developments in atrophic age-related macular degeneration. British Journal of Ophthalmology. 2016;100(1):122–127

by Mohammad Shazaib on Oct 02, 2020

Your creative contribution

0 / 200

Added via the text editor